ReviewLancet (London, England)2020
COVID-19 and Italy: what next?
Review in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 12 registered trials, which are not on this map. Cited by 1,406 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (ELEVATE Trial)
Gastrointestinal Endoscopy in the Era of COVID-19: a Multinational Survey
The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19
Sitagliptin Treatment in Diabetic COVID-19 Positive Patients: Retrospective Study
Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care
Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury by Machine Learning: a Multicenter Retrospective Cohort Study.
Scheme of Primary Prevention of Infection by COVID-19, in Workers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia
RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19
Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus: a Dilemma
The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU: A Pilot Study
Intensive Dose Tinzaparin in Hospitalized COVID19 Patients
Who cites it
1,406 citing papers in PubMed, 5 syntheses or guidelines pooled it, 3,347 citations in OpenAlex.
- The Use of Wearable Devices to Measure Sedentary Behavior during COVID-19: Systematic Review and Future Recommendations.Sensors (Basel, Switzerland) · 2023Pooled it
- Prevalence of hypertension and associated risks in hospitalized patients with COVID-19: a meta-analysis of meta-analyses with 1468 studies and 1,281,510 patients.Systematic reviews · 2022Pooled it
- Lymphocyte count is a universal predictor of health outcomes in COVID-19 patients before mass vaccination: A meta-analytical study.Journal of global health · 2022Pooled it
- What Makes Urban Communities More Resilient to COVID-19? A Systematic Review of Current Evidence.International journal of environmental research and public health · 2022Pooled it
- Comprehensive estimation for the length and dispersion of COVID-19 incubation period: a systematic review and meta-analysis.Infection · 2022Pooled it
- Evaluating the global psychotrauma screen total score using item response theory in an Italian community sample.European journal of psychotraumatology · 2026Article
- Minimizing Societal Cost of Epidemics: Optimal Catastrophe Insurance Compensation Allocation.Risk analysis : an official publication of the Society for Risk Analysis · 2026Article
- Electronic measurement of frequency and duration of close nurse-patient contacts during patient care in intensive and intermediate care units: a cross-sectional observational study.Infection prevention in practice · 2026Article
- Age and comorbidity in COVID-19 mortality: a retrospective cohort study using multivariable regression and interaction analyses.BMC infectious diseases · 2026Article
- Unveiling the narrative: Italian media's role in shaping public health messaging during COVID-19 - A corpus-assisted discourse analysis.BMC public health · 2026Article
- The future of severe acute respiratory syndrome-cornavirus and coronavirus disease.World journal of pediatrics : WJP · 2026Article
- What drives urban pandemic control performance in China? A configurational analysis of the resource-performance paradox.Frontiers in public health · 2026Article
- Epidemiological Trends of COVID-19 Infection and Symptom Incidence in China Following the Adjustment of Zero-COVID Policy: A Prospective, Community-Based Cohort Study.Transboundary and emerging diseases · 2026Article
- COVID-19 in Poland: potential associations with epidemiology, population and healthcare quality.Archives of medical science : AMS · 2026Article
- A decision support tool for the location, districting and dimensioning of Community Health Houses.Health care management science · 2025Article
- Comparative Assessment of Viral Load Retention in Surgical and Fabric Masks Worn by COVID-19 Patients.Viruses · 2025Article
- Unmasking pandemic patterns: decoding the COVID-19's impact on mortality in Italy with Generalized Gamma overdispersion model.BMC public health · 2025Article
- Adjusting hospital reimbursements to the onset of a new disease: Lesson from Covid-19.Health policy OPEN · 2025Article
- Optical Coherence Tomography (OCT) Findings in Post-COVID-19 Healthcare Workers.Journal of imaging · 2025Article
- Dynamic and static analysis of environmental variables in coronavirus spread.Scientific reports · 2025Article
1,346 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 100 countries in a matter of weeks. A global response to prepare health systems worldwide is imperative. Although containment measures in China have reduced new cases by more than 90%, this reduction is not the case elsewhere, and Italy has been particularly affected. There is now grave concern regarding the Italian national health system's capacity to effectively respond to the needs of patients who are infected and require intensive care for SARS-CoV-2 pneumonia. The percentage of patients in intensive care reported daily in Italy between March 1 and March 11, 2020, has consistently been between 9% and 11% of patients who are actively infected. The number of patients infected since Feb 21 in Italy closely follows an exponential trend. If this trend continues for 1 more week, there will be 30 000 infected patients. Intensive care units will then be at maximum capacity; up to 4000 hospital beds will be needed by mid-April, 2020. Our analysis might help political leaders and health authorities to allocate enough resources, including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. If the Italian outbreak follows a similar trend as in Hubei province, China, the number of newly infected patients could start to decrease within 3-4 days, departing from the exponential trend. However, this cannot currently be predicted because of differences between social distancing measures and the capacity to quickly build dedicated facilities in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.